4DX — 4DMedical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$115.73m
- AU$104.60m
- AU$3.75m
Annual cashflow statement for 4DMedical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -2.85 | -2.19 | -4.4 | -4.18 | -2.66 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.65 | -14.5 | -25.3 | -22.7 | -30.9 |
| Capital Expenditures | -1.16 | -0.952 | -3.5 | -1.61 | -1.17 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.372 | 0.372 | 0 | — | -38.9 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.786 | -0.58 | -3.5 | -1.61 | -40 |
| Financing Cash Flow Items | -1.5 | -6.38 | 0 | -1.19 | -2.05 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.8 | 87.6 | -0.995 | 42.7 | 31.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.34 | 72.5 | -29.8 | 18.5 | -39 |